Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?


Kilickap S., Basal F. B., Demirkazik A., Gursoy P., Demirci U., Erman M., ...More

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30, pp.637, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 30
  • City: Barcelona
  • Country: Spain
  • Page Numbers: pp.637
  • Hacettepe University Affiliated: Yes